マーケットレポート詳細
カプセル(Empty Capsule)の世界市場：タイプ別、機能別2028年予測
Empty Capsules Market by Type (Gelatin, Non-gelatin), Functionality (Immediate-Release, Sustained-Release, Delayed Release), Therapeutic Application, End User (Pharmaceutical, Nutraceutical, Cosmetic, Reference Laboratories) & Region - Global Forecasts to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年3月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文240ページになります。
- 商品コード：MAM3213
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
カプセル(Empty Capsule)の世界市場規模は2023年の32億ドルから、2028年までに49億ドルへと拡大し、その間の市場の平均年成長率は9.3%で推移することが見込まれています。
レポートはカプセル(Empty Capsule)の世界市場について2028年までの市場予測データ(金額US$、数量ベースUnits)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（タイプ別市場、機能性別市場、等）を中心に構成されています。また競合状況、主要企業情報（16社）、市場ダイナミクス、バリューチェーン分析などの分析も加味し、カプセル(Empty Capsule)市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆カプセル(Empty Capsule)の世界市場予測2021-2028年
・市場規模(US$)
・数量ベース(Units)
◆タイプ別、市場-2028年
ゼラチンカプセル
・豚ゼラチン
・牛ゼラチン
・骨粉
・その他ゼラチン原料
非ゼラチンカプセル
・ヒドロキシプロピルメチルセルロース（HPMC）
・プルラン、でんぷん
※(市場規模US$)
※(ゼラチンカプセル、非ゼラチンカプセルの大分類については数量データ掲載Units)
◆機能別、市場-2028年
・即時放出カプセル
・徐放性カプセル
・遅延放出カプセル
※(市場規模US$)
◆治療用途別、市場-2028年
・抗生物質、抗菌薬
・栄養補助食品
・制酸剤、整腸剤
・抗貧血薬
・抗炎症薬
・心血管治療薬
・咳、風邪薬
・その他治療用途
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・製薬業界
・栄養産業
・化粧品業界
・研究所
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・価格分析
・バリューチェーン分析
・エコシステム分析
・業界構造分析（ファイブフォース分析）
・特許分析
・貿易分析
・競合状況
・市場シェア分析
◆カプセル(Empty Capsule)の主要企業プロフィール動向
・CAPSUGEL (LONZA GROUP LTD)
・ACG
・株式会社三菱ケミカルホールディングス
・CAPSCANADA CORPORATION
・NATURAL CAPSULES
・SUHEUNG
・NECTAR LIFESCIENCES LTD
・QINGDAO YIQING MEDICINAL CAPSULE (BAOTOU DONGBAO BIOTECHNOLOGY CO, LTD)
・SHANXI GUANGSHENG MEDICINAL CAPSULE
・HEALTHCAPS INDIA
・MEDI-CAPS
・SNAIL PHARMA INDUSTRY
・ROXLOR
・SUNIL HEALTHCARE
・BIOCAPS ENTERPRISE
・BRIGHT PHARMA CAPS
（その他企業）
・COMED CHEMICALS
・SAVIOUR CAPS
・FORTCAPS HEALTHCARE
・SHAOXING ZHONGYA CAPSULE
・ERAWAT PHARMA LIMITED
・FARMACAPSULAS
・ZHEJIANG YUEXI CAPSULE
・LFA MACHINES OXFORD
・SHAOXING KANGKE CAPSULE
・SHREE PHARMA CAPS
（全240頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
・ FIGURE 1 EMPTY CAPSULES MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED 35
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT 36
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
・ FIGURE 2 RESEARCH DESIGN 37
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH 38
・ FIGURE 3 EMPTY CAPSULES MARKET: PRIMARY RESPONDENTS
2.2 MARKET ESTIMATION METHODOLOGY
・ FIGURE 4 EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VALUE (2022)
・ FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
・ FIGURE 6 MARKET VOLUME ESTIMATION, 2022
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
・ FIGURE 7 INSIGHTS ON EMPTY CAPSULES MARKET FROM PRIMARY EXPERTS
2.3 MARKET GROWTH RATE PROJECTIONS
・ FIGURE 8 EMPTY CAPSULES MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.4 DATA TRIANGULATION
・ FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY
・ FIGURE 10 EMPTY CAPSULES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 11 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 EMPTY CAPSULES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 14 GEOGRAPHICAL SNAPSHOT OF EMPTY CAPSULES MARKET
4 PREMIUM INSIGHTS
4.1 EMPTY CAPSULES MARKET OVERVIEW
・ FIGURE 15 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE GROWTH
4.2 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE AND COUNTRY (2022)
・ FIGURE 16 GELATIN CAPSULES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 EMPTY CAPSULES MARKET SHARE, BY APPLICATION, 2023 VS. 2028
・ FIGURE 17 ANTIBIOTIC AND ANTIBACTERIAL DRUGS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 19 EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・ TABLE 1 EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 INCREASING DEMAND FOR NUTRACEUTICALS
5.2.1.2 GROWTH IN PHARMACEUTICAL MARKET AND INCREASING NUMBER OF CLINICAL TRIALS AND R&D ACTIVITIES
5.2.1.3 ADVANCEMENTS IN CAPSULE DELIVERY TECHNOLOGIES
5.2.1.4 BENEFITS OF CAPSULES OVER OTHER DOSAGE FORMS
5.2.2 RESTRAINTS
5.2.2.1 CULTURAL PRACTICES AND DIETARY RESTRICTIONS
5.2.3 OPPORTUNITIES
5.2.3.1 EXPANSION OF CAPSULE PRODUCTION IN EMERGING COUNTRIES
5.2.3.2 DEVELOPMENT OF HALAL GELATIN AND VEGETARIAN CAPSULES
5.2.4 CHALLENGES
5.2.4.1 RISING PRICES AND LOWER AVAILABILITY OF RAW MATERIALS IN GELATIN INDUSTRY
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
・ FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS
5.4 PRICING ANALYSIS
・ TABLE 2 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION (2022)
5.5 TECHNOLOGY ANALYSIS
5.5.1 ENTERIC CAPSULE TECHNOLOGIES
5.5.2 PROTEIN DELIVERY CAPSULE TECHNOLOGIES
5.6 VALUE CHAIN ANALYSIS
・ FIGURE 21 EMPTY CAPSULES MARKET: VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
・ FIGURE 22 ECOSYSTEM ANALYSIS: EMPTY CAPSULES MARKET
・ TABLE 3 ROLE IN ECOSYSTEM 62
5.8 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 4 EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
・ FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EMPTY CAPSULES
・ FIGURE 24 KEY BUYING CRITERIA FOR EMPTY CAPSULES
5.10 PATENT ANALYSIS
・ FIGURE 25 PATENT APPLICATIONS RELATED TO EMPTY CAPSULES, JANUARY 2012–MARCH 2023
・ TABLE 5 LIST OF FEW PATENTS IN EMPTY CAPSULES MARKET
5.11 TRADE ANALYSIS
・ TABLE 6 EXPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)
・ TABLE 7 IMPORT DATA FOR HS CODE 960200 (TOP 10 COUNTRIES)
5.12 REGULATORY ANALYSIS
5.13 PHARMACEUTICAL GELATIN MARKET
5.14 INDUSTRY TRENDS
5.14.1 RISING DEMAND FOR EMPTY CAPSULES IN NUTRACEUTICAL AND COSMETICS INDUSTRIES
5.14.2 GROWING DEMAND AND ADOPTION OF VEGETARIAN/NON-GELATIN CAPSULES
6 EMPTY CAPSULES MARKET, BY TYPE
6.1 INTRODUCTION
・ TABLE 8 EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 9 EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (BILLION UNITS)
6.2 GELATIN CAPSULES
・ TABLE 10 GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 11 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 12 GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
・ TABLE 13 NORTH AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 14 EUROPE: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 15 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 PORCINE GELATIN 76
6.2.1.1 PORCINE GELATIN SEGMENT TO DOMINATE MARKET
・ TABLE 16 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 17 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 18 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 19 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 BOVINE-DERIVED GELATIN
6.2.2.1 BOVINE-DERIVED GELATIN WIDELY ACCEPTED IN HALAL PHARMACEUTICALS MARKET 78
・ TABLE 20 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 21 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 22 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 23 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 BONE MEAL
6.2.3.1 BONE MEAL GELATIN GAINED IMPORTANCE IN RECENT YEARS
・ TABLE 24 BONE MEAL GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 25 NORTH AMERICA: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 26 EUROPE: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 27 ASIA PACIFIC: BONE MEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 OTHER GELATIN SOURCES
・ TABLE 28 OTHER GELATIN SOURCE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 29 NORTH AMERICA: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 30 EUROPE: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 31 ASIA PACIFIC: OTHER GELATIN SOURCE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 NON-GELATIN CAPSULES
・ TABLE 32 NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 33 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 34 NON-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
・ TABLE 35 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 36 EUROPE: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 37 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 HYDROXYPROPYL METHYLCELLULOSE
6.3.1.1 HPMC DOMINATES NON-GELATIN CAPSULES MARKET
・ TABLE 38 HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 39 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 40 EUROPE: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 41 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 PULLULAN AND STARCH
6.3.2.1 HIGH MANUFACTURING COSTS OFFSET ADVANTAGEOUS ASPECTS OF PULLULAN AND STARCH
・ TABLE 42 PULLULAN AND STARCH CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 43 NORTH AMERICA: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 44 EUROPE: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 45 ASIA PACIFIC: PULLULAN AND STARCH CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 EMPTY CAPSULES MARKET, BY FUNCTIONALITY
7.1 INTRODUCTION
・ TABLE 46 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
7.2 IMMEDIATE-RELEASE CAPSULES
7.2.1 INCREASING APPLICATIONS OF IMMEDIATE-RELEASE CAPSULES TO PROPEL MARKET
・ TABLE 47 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 48 NORTH AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 49 EUROPE: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 50 ASIA PACIFIC: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 SUSTAINED-RELEASE CAPSULES
7.3.1 RISING USE OF SUSTAINED-RELEASE FORMULATIONS IN TREATING CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 51 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 52 NORTH AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 53 EUROPE: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 54 ASIA PACIFIC: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 DELAYED-RELEASE CAPSULES
7.4.1 GROWING PREFERENCE FOR TARGETED DRUG DELIVERY TO FUEL MARKET GROWTH
・ TABLE 55 DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 56 NORTH AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 57 EUROPE: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 58 ASIA PACIFIC: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION
8.1 INTRODUCTION
・ TABLE 59 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
8.2 ANTIBIOTIC AND ANTIBACTERIAL DRUGS
8.2.1 EMERGENCE OF NOVEL ANTIBIOTICS IN CAPSULE FORM AND INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
・ TABLE 60 EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY REGION, 2021–2028 (USD MILLION) 102
・ TABLE 61 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 62 EUROPE: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 63 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIBIOTIC AND ANTIBACTERIAL DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 DIETARY SUPPLEMENTS
8.3.1 RISING DEMAND FOR DIETARY SUPPLEMENTS TO SUPPORT GROWTH
・ TABLE 64 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 65 NORTH AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 104
・ TABLE 66 EUROPE: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 67 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 105
8.4 ANTACID AND ANTIFLATULENT PREPARATIONS
8.4.1 INCREASING DEMAND FOR GASTROINTESTINAL FORMULATIONS TO DRIVE MARKET
・ TABLE 68 EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 69 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 70 EUROPE: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 71 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 ANTIANEMIC PREPARATIONS
8.5.1 RISING INCIDENCE OF ANEMIA WORLDWIDE TO DRIVE GROWTH
・ TABLE 72 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 73 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 74 EUROPE: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 75 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 ANTI-INFLAMMATORY DRUGS
8.6.1 RISING EMPHASIS ON GENERICS TO FAVOR MARKET GROWTH
・ TABLE 76 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 77 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 78 EUROPE: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 79 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.7 CARDIOVASCULAR THERAPY DRUGS
8.7.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO CONTRIBUTE TO MARKET GROWTH
・ TABLE 80 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 81 NORTH AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 82 EUROPE: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 83 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.8 COUGH AND COLD DRUGS
8.8.1 GROWING ADOPTION OF OTC FORMULATIONS AND SELF-MEDICATION PRACTICES TO DRIVE GROWTH
・ TABLE 84 EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 85 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 86 EUROPE: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 87 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COUGH AND COLD DRUGS, BY COUNTRY, 2021–2028 (USD MILLION)
8.9 OTHER THERAPEUTIC APPLICATIONS
・ TABLE 88 EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 89 NORTH AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 90 EUROPE: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 91 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 EMPTY CAPSULES MARKET, BY END USER
9.1 INTRODUCTION
・ TABLE 92 EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL INDUSTRY
9.2.1 INCREASING EMPHASIS ON DRUG DEVELOPMENT TO DRIVE GROWTH
・ TABLE 93 EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 94 NORTH AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 95 EUROPE: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 96 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 NUTRACEUTICAL INDUSTRY
9.3.1 INCREASING DEMAND FOR DIETARY SUPPLEMENTS IN DEVELOPED AND DEVELOPING COUNTRIES TO SUPPORT GROWTH 121
・ TABLE 97 EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 98 NORTH AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 99 EUROPE: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 100 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 COSMETICS INDUSTRY
9.4.1 GELATIN-BASED CAPSULES ARE IDEAL FOR DELIVERING COSMETIC PRODUCTS
・ TABLE 101 EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 102 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 103 EUROPE: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 104 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 RESEARCH LABORATORIES
9.5.1 RISING CLINICAL TRIAL ACTIVITY TO DRIVE MARKET GROWTH
・ TABLE 105 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 106 NORTH AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 107 EUROPE: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 108 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
10 EMPTY CAPSULES MARKET, BY REGION
10.1 INTRODUCTION
・ TABLE 109 EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 110 EMPTY CAPSULES MARKET, BY REGION, 2021–2028 (BILLION UNITS)
10.2 NORTH AMERICA
・ FIGURE 26 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT
・ TABLE 111 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 112 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 113 NORTH AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 114 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 115 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 116 NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 117 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 US TO DOMINATE NORTH AMERICAN MARKET DURING FORECAST PERIOD
・ TABLE 118 US: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 119 US: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 120 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 121 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 122 US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 123 US: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 RISING GOVERNMENT FOCUS ON UTILIZATION OF GENERICS AS MEANS FOR CONTROLLING HEALTHCARE EXPENDITURE TO DRIVE GROWTH
・ TABLE 124 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 125 CANADA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 126 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 127 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 128 CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 129 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
・ TABLE 130 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 131 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 132 EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 133 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 134 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 135 EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 136 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 PRESENCE OF LARGE NUMBER OF PHARMACEUTICAL AND NUTRACEUTICAL MANUFACTURERS PROPELLING DEMAND FOR EMPTY CAPSULES
・ TABLE 137 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 138 GERMANY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 139 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 140 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 141 GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 142 GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 RISING ADOPTION OF GENERICS TO DRIVE MARKET GROWTH
・ TABLE 143 UK: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 144 UK: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 145 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 146 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 147 UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 148 UK: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 HIGH DEMAND FOR PHARMACEUTICAL PRODUCTS TO DRIVE MARKET GROWTH
・ TABLE 149 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 150 FRANCE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 151 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 152 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 153 FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 154 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 GROWING PRESENCE OF SMALL AND MEDIUM-SIZED CMOS LIKELY TO DRIVE MARKET
・ TABLE 155 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 156 ITALY: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 157 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 158 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 159 ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 160 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 CONSOLIDATION OF BIOTECHNOLOGY SECTOR AND AVAILABILITY OF GOVERNMENT SUPPORT TO DRIVE GROWTH
・ TABLE 161 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 162 SPAIN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 163 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 164 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 165 SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 166 SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 REST OF EUROPE
・ TABLE 167 REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 168 REST OF EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 169 REST OF EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 170 REST OF EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 171 REST OF EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 172 REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
・ FIGURE 27 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT
・ TABLE 173 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 174 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 175 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 176 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 177 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 178 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 179 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 CHINA
10.4.1.1 LOW MANUFACTURING COSTS ON ACCOUNT OF AVAILABILITY OF RAW MATERIALS TO ACCELERATE GROWTH
・ TABLE 180 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 181 CHINA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 182 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 183 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 184 CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 185 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 JAPAN TO BE LARGEST MARKET FOR EMPTY CAPSULES IN ASIA PACIFIC
・ TABLE 186 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 187 JAPAN: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 188 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 189 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 190 JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 191 JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 INCREASED EXPORTS OF EMPTY CAPSULES TO DRIVE MARKET GROWTH
・ TABLE 192 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 193 INDIA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 194 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 195 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 196 INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 197 INDIA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
・ TABLE 198 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 199 REST OF ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 200 REST OF ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 201 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 202 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 203 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 ASIA PACIFIC: RECESSION IMPACT
10.5 LATIN AMERICA
10.5.1 STRATEGIC EXPANSIONS BY LEADING MARKET PLAYERS TO DRIVE GROWTH
・ TABLE 204 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 205 LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 206 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 207 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 208 LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 209 LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 LATIN AMERICA: RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
・ TABLE 210 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 211 MIDDLE EAST & AFRICA: GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 212 MIDDLE EAST & AFRICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 213 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
・ TABLE 214 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 215 MIDDLE EAST & AFRICA: EMPTY CAPSULES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
・ FIGURE 28 EMPTY CAPSULES MARKET: STRATEGIES ADOPTED
11.3 MARKET SHARE ANALYSIS
・ FIGURE 29 EMPTY CAPSULES MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
・ TABLE 216 EMPTY CAPSULES MARKET: DEGREE OF COMPETITION
11.4 REVENUE ANALYSIS
・ FIGURE 30 REVENUE ANALYSIS FOR KEY COMPANIES (2020–2022)
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
・ FIGURE 31 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX, 2022
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
・ FIGURE 32 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
11.7.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
・ TABLE 217 OVERALL FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7.2 INDUSTRY FOOTPRINT OF COMPANIES (25 COMPANIES)
・ TABLE 218 INDUSTRY FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
・ TABLE 219 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
11.7.4 OFFERING FOOTPRINT OF COMPANIES (25 COMPANIES)
・ TABLE 220 OFFERING FOOTPRINT ANALYSIS OF KEY PLAYERS
11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES
・ TABLE 221 EMPTY CAPSULES MARKET: DETAILED LIST OF KEY START-UPS/SMES
・ TABLE 222 EMPTY CAPSULES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 PRODUCT LAUNCHES 196
・ TABLE 223 EMPTY CAPSULES MARKET: PRODUCT LAUNCHES, JANUARY 2020–MARCH 2023
11.9.2 DEALS
・ TABLE 224 EMPTY CAPSULES MARKET: DEALS, JANUARY 2020–MARCH 2023
11.9.3 OTHER DEVELOPMENTS
・ TABLE 225 EMPTY CAPSULES MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MARCH 2023
12 COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS) *
12.1 KEY PLAYERS
12.1.1 CAPSUGEL (LONZA GROUP LTD.)
・ TABLE 226 CAPSUGEL (LONZA GROUP): BUSINESS OVERVIEW
・ FIGURE 33 LONZA GROUP LTD.: COMPANY SNAPSHOT (2022)
12.1.2 ACG
・ TABLE 227 ACG: BUSINESS OVERVIEW
12.1.3 MITSUBISHI CHEMICAL HOLDINGS CORPORATION
・ TABLE 228 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): BUSINESS OVERVIEW
・ FIGURE 34 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION): COMPANY SNAPSHOT (2021)
12.1.4 CAPSCANADA CORPORATION
・ TABLE 229 CAPSCANADA CORPORATION: BUSINESS OVERVIEW
12.1.5 NATURAL CAPSULES 209
・ TABLE 230 NATURAL CAPSULES: BUSINESS OVERVIEW
・ FIGURE 35 NATURAL CAPSULES: COMPANY SNAPSHOT (2021)
12.1.6 SUHEUNG
・ TABLE 231 SUHEUNG: BUSINESS OVERVIEW 211
12.1.7 NECTAR LIFESCIENCES LTD.
・ TABLE 232 NECTAR LIFESCIENCES LTD.: BUSINESS OVERVIEW
・ FIGURE 36 NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT (2021)
12.1.8 QINGDAO YIQING MEDICINAL CAPSULE (BAOTOU DONGBAO BIOTECHNOLOGY CO., LTD.)
・ TABLE 233 QINGDAO YIQING MEDICINAL CAPSULE: BUSINESS OVERVIEW
12.1.9 SHANXI GUANGSHENG MEDICINAL CAPSULE
・ TABLE 234 SHANXI GUANGSHENG MEDICINAL CAPSULE: BUSINESS OVERVIEW
12.1.10 HEALTHCAPS INDIA 217
・ TABLE 235 HEALTHCAPS INDIA: BUSINESS OVERVIEW
12.1.11 MEDI-CAPS
・ TABLE 236 MEDI-CAPS: BUSINESS OVERVIEW 219
・ FIGURE 37 MEDI-CAPS: COMPANY SNAPSHOT (2021)
12.1.12 SNAIL PHARMA INDUSTRY
・ TABLE 237 SNAIL PHARMA INDUSTRY: BUSINESS OVERVIEW
12.1.13 ROXLOR
・ TABLE 238 ROXLOR: BUSINESS OVERVIEW
12.1.14 SUNIL HEALTHCARE 223
・ TABLE 239 SUNIL HEALTHCARE: BUSINESS OVERVIEW
・ FIGURE 38 SUNIL HEALTHCARE: COMPANY SNAPSHOT (2021)
12.1.15 BIOCAPS ENTERPRISE
・ TABLE 240 BIOCAPS ENTERPRISE: BUSINESS OVERVIEW
12.1.16 BRIGHT PHARMA CAPS
・ TABLE 241 BRIGHT PHARMA CAPS: BUSINESS OVERVIEW
12.2 OTHER COMPANIES
12.2.1 COMED CHEMICALS 229
・ TABLE 242 COMED CHEMICALS: BUSINESS OVERVIEW
12.2.2 SAVIOUR CAPS
・ TABLE 243 SAVIOUR CAPS: BUSINESS OVERVIEW
12.2.3 FORTCAPS HEALTHCARE
・ TABLE 244 FORTCAPS HEALTHCARE: BUSINESS OVERVIEW
12.2.4 SHAOXING ZHONGYA CAPSULE
・ TABLE 245 SHAOXING ZHONGYA CAPSULE: BUSINESS OVERVIEW
12.2.5 ERAWAT PHARMA LIMITED
・ TABLE 246 ERAWAT PHARMA LIMITED: BUSINESS OVERVIEW
12.2.6 FARMACAPSULAS
・ TABLE 247 FARMACAPSULAS: BUSINESS OVERVIEW
12.2.7 ZHEJIANG YUEXI CAPSULE
12.2.8 LFA MACHINES OXFORD
12.2.9 SHAOXING KANGKE CAPSULE
12.2.10 SHREE PHARMA CAPS 240
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW, RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.